Nephrogenic adenoma in a patient with chronic renal failure associated with intravesical treatment with thiotepa.
We describe a patient with chronic renal failure and transitional cell carcinoma, in whom a nephrogenic adenoma of the bladder was diagnosed after a course of intravesical thiotepa treatment.
Embon
O M
OM
Department of Urology, Rebecca Sieff Government Hospital, Safed, Israel.
Turani
H
H
Gold
C H
CH
Sazbon
A
A
D000236:Adenoma / Q000139:chemically induced*; D000283:Administration, Intravesical; D002295:Carcinoma, Transitional Cell / Q000150:complications / Q000188:drug therapy; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications*; D008297:Male; D008875:Middle Aged; D013852:Thiotepa / Q000009:adverse effects* / Q000627:therapeutic use; D001749:Urinary Bladder Neoplasms / Q000139:chemically induced* / Q000150:complications / Q000188:drug therapy
D013852:Thiotepa